Is a complete BST/APE1 research report available?

No complete published report is available for bst/APE1 (BST/APE1) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BST/APE1 (BST/APE1)

Stuttgart Stock Exchange: BST/APE1 · EUR

€2.64

+0.02 (+0.8%)· Recorded snapshot

Market cap	2.9M
Revenue (ttm)	90K
Net income (ttm)	-7.4M
EPS (ttm)	-€7.55

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 90K
Net income (ttm): -7.4M
EPS (ttm): -€7.55
Market cap: 2.9M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Metric	Value
Amount currency	EUR
Country	Switzerland
Country code	DE
Earnings date	2026-11-09
Employees	3
Employees change	1
Employees growth	50%
Enterprise value	EUR 2.1M
Exchange	Stuttgart Stock Exchange
Financial currency	CHF
Financial report date	2026-06-30
First seen	2026-10-27
Fiscal year end	December
Founded	2002
Industry	Biotechnology
Is primary listing	No
ISIN number	US00654J2069
Last refreshed	2026-10-28
Last stock split date	2023-10-23
Last stock split type	Reverse
Market cap	EUR 2.9M
Next earnings date	2026-11-09
Price	EUR 2.64
Price currency	EUR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-27
Symbol	bst/APE1
Website	https://www.addextherapeutics.com

Metric

Value

Amount currency

EUR

Country

Switzerland

Country code

Earnings date

2026-11-09

Employees

Employees change

Employees growth

50%

Enterprise value

EUR 2.1M

Exchange

Stuttgart Stock Exchange

Financial currency

CHF

Financial report date

2026-06-30

First seen

2026-10-27

Fiscal year end

December

Founded

2002

Industry

Biotechnology

Is primary listing

ISIN number

US00654J2069

Last refreshed

2026-10-28

Last stock split date

2023-10-23

Last stock split type

Reverse

Market cap

EUR 2.9M

Next earnings date

2026-11-09

Price

EUR 2.64

Price currency

EUR

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-27

Symbol

bst/APE1

Website

https://www.addextherapeutics.com

Metric	Value
Earnings yield	-285.87%
EV/Sales	23.6x
FCF / EV yield	-121.57%
FCF yield	-89.93%
P/B ratio	1.39x
P/S ratio	31.89x
Price / tangible book value	1.39x
Sector forward P/E	14.95x
Sector P/E	40.18x

Metric

Value

Earnings yield

-285.87%

EV/Sales

23.6x

FCF / EV yield

-121.57%

FCF yield

-89.93%

P/B ratio

1.39x

P/S ratio

31.89x

Price / tangible book value

1.39x

Sector forward P/E

14.95x

Sector P/E

40.18x

Metric	Value
Operating margin	-3,130.67%
Pretax margin	-8,266.9%
Profit per employee	EUR -2.5M
Revenue per employee	EUR 29,996
ROA	-27.12%
ROA (5Y)	-30.59%
ROCE	-122.88%
ROE	-150.58%
ROE (5Y)	-92.85%
ROIC	-35.19%
SBC / revenue	49.06%

Metric

Value

Operating margin

-3,130.67%

Pretax margin

-8,266.9%

Profit per employee

EUR -2.5M

Revenue per employee

EUR 29,996

ROA

-27.12%

ROA (5Y)

-30.59%

ROCE

-122.88%

ROE

-150.58%

ROE (5Y)

-92.85%

ROIC

-35.19%

SBC / revenue

49.06%

Metric	Value
EPS growth quarters	2
EPS growth years	0
Net income growth quarters	1
Net income growth years	0
Revenue growth	-50.34%
Revenue growth (Q)	-72.65%
Revenue growth (QoQ)	29.35%
Revenue growth 10Y	-21.91%
Revenue growth 3Y	-66.19%
Revenue growth 5Y	-53.9%
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth

-50.34%

Revenue growth (Q)

-72.65%

Revenue growth (QoQ)

29.35%

Revenue growth 10Y

-21.91%

Revenue growth 3Y

-66.19%

Revenue growth 5Y

-53.9%

Revenue growth years

Metric	Value
Depreciation and amortization	EUR -3,892
EBIT	EUR -2.8M
EBITDA	EUR -2.8M
EPS	EUR -7.55
Financing cash flow	EUR 857,763
Free cash flow	EUR -2.6M
Free cash flow minus SBC	EUR -2.6M
Gross profit	EUR -294,847
Investing cash flow	EUR 61,389
Net borrowing	EUR -40,994
Net cash flow	EUR -1.7M
Net income	EUR -7.4M
Operating cash flow minus SBC	EUR -2.6M
Operating income	EUR -2.8M
Revenue	EUR 89,988
Stock-based compensation	EUR 44,148

Metric

Value

Depreciation and amortization

EUR -3,892

EBIT

EUR -2.8M

EBITDA

EUR -2.8M

EPS

EUR -7.55

Financing cash flow

EUR 857,763

Free cash flow

EUR -2.6M

Free cash flow minus SBC

EUR -2.6M

Gross profit

EUR -294,847

Investing cash flow

EUR 61,389

Net borrowing

EUR -40,994

Net cash flow

EUR -1.7M

Net income

EUR -7.4M

Operating cash flow minus SBC

EUR -2.6M

Operating income

EUR -2.8M

Revenue

EUR 89,988

Stock-based compensation

EUR 44,148

Metric	Value
Altman Z-Score	-146.51
Book value per share	EUR 0.02
Debt / equity	0.04
Interest coverage	-818.25
Long-term assets	EUR 2.6M
Long-term liabilities	EUR 227,729
Net cash (debt)	EUR 747,291
Net cash / market cap	26.04%
Net cash growth	-69.51%
Net debt / equity	-0.36
Piotroski F-Score	1
Property, plant and equipment	EUR 82,422
Shareholders' equity	EUR 2.1M
Tangible book value	EUR 2.1M
Tangible book value per share	EUR 0.02
Total assets	EUR 3.8M
Total cash	EUR 831,240
Total debt	EUR 83,950
Total liabilities	EUR 1.7M

Metric

Value

Altman Z-Score

-146.51

Book value per share

EUR 0.02

Debt / equity

0.04

Interest coverage

-818.25

Long-term assets

EUR 2.6M

Long-term liabilities

EUR 227,729

Net cash (debt)

EUR 747,291

Net cash / market cap

26.04%

Net cash growth

-69.51%

Net debt / equity

-0.36

Piotroski F-Score

Property, plant and equipment

EUR 82,422

Shareholders' equity

EUR 2.1M

Tangible book value

EUR 2.1M

Tangible book value per share

EUR 0.02

Total assets

EUR 3.8M

Total cash

EUR 831,240

Total debt

EUR 83,950

Total liabilities

EUR 1.7M

Metric	Value
Asset turnover	0.01
Current assets	EUR 1.1M
Current liabilities	EUR 1.5M
Current ratio	0.76
Net working capital	EUR -1.1M
Quick ratio	0.58
Working capital	EUR -353,551
Working capital turnover	0.15

Metric

Value

Asset turnover

0.01

Current assets

EUR 1.1M

Current liabilities

EUR 1.5M

Current ratio

0.76

Net working capital

EUR -1.1M

Quick ratio

0.58

Working capital

EUR -353,551

Working capital turnover

0.15

Metric	Value
Buyback yield / dilution	-19.49%
Shareholder yield	-19.49%

Metric

Value

Buyback yield / dilution

-19.49%

Shareholder yield

-19.49%

Metric	Value
150-day SMA	EUR 4.50
1D price change	0.76%
1M price change	-15.92%
1M total return	-15.92%
1W price change	6.45%
1W total return	6.45%
20-day SMA	EUR 2.60
200-day SMA	EUR 4.82
3M price change	-44.54%
3M total return	-44.54%
50-day SMA	EUR 2.97
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 7.30
52-week high date	2025-11-17
52-week low	EUR 2.38
52-week low date	2026-09-30
5Y price change	-99.66%
5Y return CAGR	-68%
5Y total return	-99.66%
6M price change	-52.43%
6M total return	-52.43%
All-time high	EUR 2,400.00
All-time high date	2021-01-21
All-time low	EUR 2.38
All-time low date	2026-09-30
Average true range (ATR)	EUR 0.11
Average volume	0
Change from 52-week high	-63.84%
Change from 52-week low	10.92%
Change from all-time high	-99.89%
Change from all-time low	10.92%
Monthly RSI	21.89
Previous close	EUR 2.62
Price vs 150-day SMA	-41.31%
Price vs 20-day SMA	1.46%
Price vs 200-day SMA	-45.24%
Price vs 50-day SMA	-11.14%
RSI	45.46
Sharpe ratio	-0.3
Sortino ratio	-0.43
Weekly RSI	17.33
YTD price change	-56%
YTD total return	-56%

Metric

Value

150-day SMA

EUR 4.50

1D price change

0.76%

1M price change

-15.92%

1M total return

-15.92%

1W price change

6.45%

1W total return

6.45%

20-day SMA

EUR 2.60

200-day SMA

EUR 4.82

3M price change

-44.54%

3M total return

-44.54%

50-day SMA

EUR 2.97

50-day SMA vs 200-day SMA

50under200

52-week high

EUR 7.30

52-week high date

2025-11-17

52-week low

EUR 2.38

52-week low date

2026-09-30

5Y price change

-99.66%

5Y return CAGR

-68%

5Y total return

-99.66%

6M price change

-52.43%

6M total return

-52.43%

All-time high

EUR 2,400.00

All-time high date

2021-01-21

All-time low

EUR 2.38

All-time low date

2026-09-30

Average true range (ATR)

EUR 0.11

Average volume

Change from 52-week high

-63.84%

Change from 52-week low

10.92%

Change from all-time high

-99.89%

Change from all-time low

10.92%

Monthly RSI

21.89

Previous close

EUR 2.62

Price vs 150-day SMA

-41.31%

Price vs 20-day SMA

1.46%

Price vs 200-day SMA

-45.24%

Price vs 50-day SMA

-11.14%

RSI

45.46

Sharpe ratio

-0.3

Sortino ratio

-0.43

Weekly RSI

17.33

YTD price change

-56%

YTD total return

-56%

Metric	Value
Float	105.2M
Shares change (QoQ)	3.43%
Shares change (YoY)	19.49%
Shares held by insiders	17.47%
Shares held by institutions	1.7%

Metric

Value

Float

105.2M

Shares change (QoQ)

3.43%

Shares change (YoY)

19.49%

Shares held by insiders

17.47%

Shares held by institutions

1.7%

BST/APE1 (BST/APE1)

Price

Financial snapshot

Fair-value bridge

Latest news · BST/APE1

Valuation

Profitability

Balance sheet

Next earnings

Sector percentile context

All BST/APE1 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BST/APE1

Frequently asked questions